Categories
All News

Global Drugs for Schistosomiasis Market in South Korea Market Size, Share, Value, and Competitive Landscape from 2020-2026

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

ALSO READ: https://www.wiseguyreports.com/reports/6216105

This report contains market size and forecasts of Drugs for Schistosomiasis in South Korea, including the following market information:
South Korea Drugs for Schistosomiasis Market Revenue, 2015-2020, 2021-2026, ($ millions)
South Korea Drugs for Schistosomiasis Market Consumption, 2015-2020, 2021-2026, (M Units)
South Korea Drugs for Schistosomiasis Production Capacity, 2015-2020, 2021-2026, (M Units)
Top Five Competitors in South Korea Drugs for Schistosomiasis Market 2019 (%)

ALSO READ: http://www.marketwatch.com/story/marble-countertops-market-2021-global-trends-market-share-industry-size-growth-opportunities-and-market-forecast-to-2027-2021-02-02

The global Drugs for Schistosomiasis market was valued at 78 million in 2019 and is projected to reach US$ 90 million by 2026, at a CAGR of 3.6% during the forecast period. While the Drugs for Schistosomiasis market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Schistosomiasis manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

ALSO READ: http://www.marketwatch.com/story/global-plastic-casters-2021-industry-trends-sales-supply-demand-analysis-forecast-to-2027-2021-02-08

This report also analyses and evaluates the COVID-19 impact on Drugs for Schistosomiasis production and consumption in South Korea
Total Market by Segment:
South Korea Drugs for Schistosomiasis Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Units)
South Korea Drugs for Schistosomiasis Market Segment Percentages, By Type, 2019 (%)
Praziquantel
Oxamniquine
Other

ALSO READ: http://www.marketwatch.com/story/grid-to-vehicle-v2g-system-market-innovations-trends-technology-and-applications-market-report-to-2021-2026-2021-02-11

South Korea Drugs for Schistosomiasis Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Units)
South Korea Drugs for Schistosomiasis Market Segment Percentages, By Application, 2019 (%)
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Drugs for Schistosomiasis Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
Total Drugs for Schistosomiasis Market Competitors Revenues Share in South Korea, by Players 2019 (%)
Total South Korea Drugs for Schistosomiasis Market Competitors Sales, by Players 2015-2020 (Estimated), (M Units)
Total South Korea Drugs for Schistosomiasis Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma

ALSO READ: http://www.marketwatch.com/story/commercial-ice-makers-and-ice-machines-market-2021-global-trends-top-players-demand-share-segmentation-and-forecast-to-2026-2021-02-19

https://murphyshockeylaw.net/